2-Nitroimidazol-5-ylmethyl as a potential bioreductively activated prodrug system: reductively triggered release of the parp inhibitor 5-bromoisoquinolinone

Ifat Shah, Declan P. Naughton, William J. D. Whish, Michael D. Threadgill

Research output: Contribution to journalArticlepeer-review

59 Citations (SciVal)

Abstract

5-Chloromethyl-1-methyl-2-nitroimidazole reacted efficiently with the anion derived from 5-bromo-isoquinolin-1-one to give 5-bromo-2-((1-methyl-2-nitroimidazol-5-yl)methyl)isoquinolin-1-one. Biomimetic reduction effected release of the 5-bromoisoquinolin-1-one. The 2-nitroimidazol-5-ylmethyl unit thus has potential for development as a general prodrug system for selective drug delivery to hypoxic tissues.
Original languageEnglish
Pages (from-to)2031-2036
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume9
Issue number14
DOIs
Publication statusPublished - 19 Jul 1999
Externally publishedYes

Fingerprint

Dive into the research topics of '2-Nitroimidazol-5-ylmethyl as a potential bioreductively activated prodrug system: reductively triggered release of the parp inhibitor 5-bromoisoquinolinone'. Together they form a unique fingerprint.

Cite this